Abstract
We report herein our preliminary results of a SAR study of quinazoline-based inhibitors of p56 lck and EGF-R tyrosine kinase activity. 1 The most potent inhibitor of p56 lck identified, RPR-108518A ( 10), has an IC 50 of 0.50 μM. The 3-chlorophenoxy- and 3-chlorothiophenoxy- derivatives 5 and 6 were also shown to be extremely potent EGF-R inhibitors.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have